OBJECTIVE: Acute lung injury with subsequent pneumonia and sepsis represents a major cause of morbidity and mortality in thermally injured patients. Production of nitric oxide by the neuronal and inducible nitric oxide synthase may be critically involved in the pathophysiology of the disease process at different time points, and thus specific inhibition at different times may represent an effective treatment regimen. DESIGN: Prospective, controlled, randomized trial. SETTING: University research laboratory. SUBJECTS: Eighteen chronically instrumented, adult, female sheep. INTERVENTIONS: Following baseline measurements, the animals were allocated to either sham-injured, nontreated controls (sham), injured, nontreated controls (control), or injured animals treated with continuous infusion of 7-nitroindazole, a specific neuronal nitric oxide synthase inhibitor, during the first 12 hrs postinjury and infusion of BBS-2, a specific inducible nitric oxide synthase inhibitor, during the next 12 hrs. Injury was induced by 48 breaths of cotton smoke and subsequent instillation of Pseudomonas aeruginosa into the lungs. All sheep were mechanically ventilated and fluid resuscitated for the entire duration of the 24-hr experiment. MEASUREMENTS AND MAIN RESULTS: The injury induced severe pulmonary dysfunction, which was associated with increases in lung edema formation, airway obstruction, and vascular endothelial growth factor, 3-nitrotyrosine, and poly(adenosine diphosphate ribose) expression in lung tissue. The treatment reduced the degree of airway obstruction and improved pulmonary gas exchange, whereas the development of lung edema was not affected. The increases in lung tissue vascular endothelial growth factor, 3-nitrotyrosine, and poly(ribose) expression were attenuated by the treatment. CONCLUSIONS: The combination of early neuronal nitric oxide synthase and delayed inducible nitric oxide synthase inhibition shows potential benefit in ovine acute lung injury by reducing nitrosative stress in the lung and limiting the degree of airway obstruction.
OBJECTIVE:Acute lung injury with subsequent pneumonia and sepsis represents a major cause of morbidity and mortality in thermally injured patients. Production of nitric oxide by the neuronal and inducible nitric oxide synthase may be critically involved in the pathophysiology of the disease process at different time points, and thus specific inhibition at different times may represent an effective treatment regimen. DESIGN: Prospective, controlled, randomized trial. SETTING: University research laboratory. SUBJECTS: Eighteen chronically instrumented, adult, female sheep. INTERVENTIONS: Following baseline measurements, the animals were allocated to either sham-injured, nontreated controls (sham), injured, nontreated controls (control), or injured animals treated with continuous infusion of 7-nitroindazole, a specific neuronal nitric oxide synthase inhibitor, during the first 12 hrs postinjury and infusion of BBS-2, a specific inducible nitric oxide synthase inhibitor, during the next 12 hrs. Injury was induced by 48 breaths of cotton smoke and subsequent instillation of Pseudomonas aeruginosa into the lungs. All sheep were mechanically ventilated and fluid resuscitated for the entire duration of the 24-hr experiment. MEASUREMENTS AND MAIN RESULTS: The injury induced severe pulmonary dysfunction, which was associated with increases in lung edema formation, airway obstruction, and vascular endothelial growth factor, 3-nitrotyrosine, and poly(adenosine diphosphate ribose) expression in lung tissue. The treatment reduced the degree of airway obstruction and improved pulmonary gas exchange, whereas the development of lung edema was not affected. The increases in lung tissue vascular endothelial growth factor, 3-nitrotyrosine, and poly(ribose) expression were attenuated by the treatment. CONCLUSIONS: The combination of early neuronal nitric oxide synthase and delayed inducible nitric oxide synthase inhibition shows potential benefit in ovine acute lung injury by reducing nitrosative stress in the lung and limiting the degree of airway obstruction.
Authors: D L Traber; H K Hawkins; P Enkhbaatar; R A Cox; F C Schmalstieg; J B Zwischenberger; L D Traber Journal: Pulm Pharmacol Ther Date: 2006-06-22 Impact factor: 3.410
Authors: Perenlei Enkhbaatar; Kazunori Murakami; Lillian D Traber; Robert Cox; John F Parkinson; Martin Westphal; Aimalohi Esechie; Naoki Morita; Marc O Maybauer; Dirk M Maybauer; Ann S Burke; Frank C Schmalstieg; Hal K Hawkins; David N Herndon; Daniel L Traber Journal: Shock Date: 2006-05 Impact factor: 3.454
Authors: Dirk M Maybauer; Marc O Maybauer; Lillian D Traber; Martin Westphal; Yoshimitsu Y Nakano; Perenlei Enkhbaatar; Naoki Morita; David N Herndon; Daniel L Traber Journal: Shock Date: 2006-11 Impact factor: 3.454
Authors: A B El-Remessy; M Al-Shabrawey; D H Platt; M Bartoli; M A Behzadian; N Ghaly; N Tsai; K Motamed; R B Caldwell Journal: FASEB J Date: 2007-03-23 Impact factor: 5.191
Authors: R Saini; S Patel; R Saluja; A A Sahasrabuddhe; M P Singh; S Habib; V K Bajpai; M Dikshit Journal: J Leukoc Biol Date: 2005-12-30 Impact factor: 4.962
Authors: Martin Westphal; Robert A Cox; Lillian D Traber; Naoki Morita; Perenlei Enkhbaatar; Frank C Schmalstieg; Hal K Hawkins; Dirk M Maybauer; Marc O Maybauer; Kazunori Murakami; Ann S Burke; Beena B Westphal-Varghese; Helen E Rudloff; John R Salsbury; Jeffrey M Jodoin; Steve Lee; Daniel L Traber Journal: Crit Care Med Date: 2006-05 Impact factor: 7.598
Authors: Matthias Lange; Atsumori Hamahata; Daniel L Traber; Rhykka Connelly; Yoshimitsu Nakano; Lillian D Traber; Frank C Schmalstieg; David N Herndon; Perenlei Enkhbaatar Journal: Burns Date: 2012-05-29 Impact factor: 2.744
Authors: Matthias Lange; Csaba Szabo; Daniel L Traber; Eszter Horvath; Atsumori Hamahata; Yoshimitsu Nakano; Lillian D Traber; Robert A Cox; Frank C Schmalstieg; David N Herndon; Perenlei Enkhbaatar Journal: Shock Date: 2012-05 Impact factor: 3.454
Authors: Matthias Lange; Atsumori Hamahata; Perenlei Enkhbaatar; Robert A Cox; Yoshimitsu Nakano; Martin Westphal; Lillian D Traber; David N Herndon; Daniel L Traber Journal: Shock Date: 2011-06 Impact factor: 3.454
Authors: Perenlei Enkhbaatar; Jianpu Wang; Fiona Saunders; Matthias Lange; Atsumori Hamahata; Sebastian Rehberg; John F Parkinson; Lillian D Traber; David N Herndon; Daniel L Traber Journal: Burns Date: 2011-02-18 Impact factor: 2.744
Authors: Matthias Lange; Rhykka Connelly; Daniel L Traber; Atsumori Hamahata; Yoshimitsu Nakano; Aimalohi Esechie; Collette Jonkam; Sanna von Borzyskowski; Lillian D Traber; Frank C Schmalstieg; David N Herndon; Perenlei Enkhbaatar Journal: Crit Care Date: 2010-07-05 Impact factor: 9.097
Authors: Sebastian Rehberg; Yusuke Yamamoto; Linda E Sousse; Collette Jonkam; Yong Zhu; Lillian D Traber; Robert A Cox; Donald S Prough; Daniel L Traber; Perenlei Enkhbaatar Journal: Crit Care Med Date: 2013-12 Impact factor: 7.598
Authors: Evgeny V Suborov; Alexey A Smetkin; Timofey V Kondratiev; Andrey Y Valkov; Vsevolod V Kuzkov; Mikhail Y Kirov; Lars J Bjertnaes Journal: BMC Anesthesiol Date: 2012-06-21 Impact factor: 2.217
Authors: Sebastian Rehberg; Yusuke Yamamoto; Eva Bartha; Linda E Sousse; Collette Jonkam; Yong Zhu; Lillian D Traber; Robert A Cox; Daniel L Traber; Perenlei Enkhbaatar Journal: Crit Care Date: 2013-05-11 Impact factor: 9.097